Related Experiment Videos
Fibrinogen degradation products in pleural effusions
British Journal of Diseases of the Chest
|April 1, 1980
Summary
Fibrinogen degradation products (FDP) in pleural fluid can help diagnose the cause of pleural effusion. Elevated FDP levels in pleural fluid, but not serum, distinguish serious conditions like malignancy and infection from heart failure.
Area of Science:
- Biochemistry
- Pulmonology
- Oncology
Background:
- Pleural effusion diagnosis can be challenging.
- Biochemical markers may aid differential diagnosis.
- Fibrinogen degradation products (FDP) are implicated in inflammatory and thrombotic processes.
Purpose of the Study:
- To evaluate the diagnostic utility of FDP in pleural fluid and serum.
- To differentiate causes of pleural effusion using FDP levels.
Main Methods:
- Analyzed FDP concentrations in pleural fluid and serum from 30 patients with various causes of pleural effusion.
- Compared FDP levels across different etiological groups: malignancy, infection, pulmonary embolism, and congestive cardiac failure.
Main Results:
- Significantly higher FDP concentrations were observed in pleural fluid for patients with malignancy, infection, and pulmonary embolism compared to those with congestive cardiac failure.
- No significant differences in serum FDP concentrations were found between the etiological groups.
Conclusions:
- Pleural fluid FDP measurement is a valuable biochemical test for the differential diagnosis of pleural effusion.
- This simple procedure complements existing diagnostic methods for pleural effusions.